It was approved by the United States Food and Drug Administration (FDA) as an antidepressant on 30 December 1985, and marketed under the name Wellbutrin.
FDA je odobrila upotrebu ovog leka kao antidepresant 30. decembra 1985. i on prodavan pod imenom Wellbutrin.